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Abstract
Background
Diabetes mellitus (DM) has been associated with increased risk for pulmonary tuberculosis
(PTB) in endemic settings but it is unknown whether PTB risk is also increased by pre-DM.
Here, we prospectively examined the association between glucose metabolism disorder
(GMD) and PTB in patients with respiratory symptoms at a tuberculosis primary care refer-
ence center in Brazil.
Methods
Oral glucose tolerance test was performed and levels of fasting plasma glucose and glyco-
hemoglobin (HbA1c) were measured in a cohort of 892 individuals presenting with respira-
tory symptoms of more than two weeks duration. Patients were also tested for PTB with
sputum cultures. Prevalence of pre-DM and DM (based on HbA1c) was estimated and
tested for association with incident PTB. Other TB risk factors including smoking history
were analyzed.
Results
The majority of the study population (63.1%) exhibited GMD based on HbA1c5.7%.
Patients with GMD had higher prevalence of PTB compared to normoglycemic patients.
Individuals with DM exhibited increased frequency of TB-related symptoms and detection of
acid-fast bacilli in sputum smears. Among patients with previous DM diagnosis, sustained
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hyperglycemia (HbA1c7.0%) was associated with increased TB prevalence. Smoking
history alone was not significantly associated with TB in our study population but the combi-
nation of smoking and HbA1c7.0% was associated with 6 times higher odds for PTB.
Conclusions
Sustained hyperglycemia and pre-DM are independently associated with active PTB. This
evidence raises the question whether improving glycemic control in diabetic TB patients
would reduce the risk of TB transmission and simultaneously reduce the clinical burden of
disease. A better understanding of mechanisms underlying these associations, especially
those suggesting that pre-DM may be a factor driving susceptibility to TB is warranted.
Introduction
Tuberculosis (TB) remains a major global health problem causing 9.6 million new cases and
1.5 million deaths in 2014 [1]. Adequate TB control at the population level requires better
understanding of interactions with potential comorbid risk factors. The most significant
acquired TB risks factors are undernutrition, smoking, AIDS, and DM [2–5]. These comorbidi-
ties increase the risk to develop active TB and the risk for adverse outcomes. Globally, 15% of
TB cases are estimated to be attributable to DM [6]. The number of people worldwide with
DM is expected to rise by 55% during the next 20 years, with the largest increase in countries
where TB is already endemic [7]. At present, seven of the 10 countries with the highest number
of DM cases also have a high TB burden [8,9]. Rising DM prevalence presents challenges in
clinical TB management since it is associated with higher risk for adverse outcomes and relapse
after the initiation of antituberculous treatment (ATT) [10–13]. In the coming years, DM will
have an increasingly important detrimental effect on global TB elimination.
It is imperative to develop a better understanding of the interactions between GMD and TB,
which may differ in a population-specific manner. Brazil is among the 22 countries identified
by the World Health Organization (WHO) that concentrate 82% of TB cases worldwide [1].
Brazil also has the highest number of DM cases within the South and Central America, totaling
12.4 million individuals [6]. Few studies have investigated the interaction between these condi-
tions systematically in this country [11,14]. In the present study, we performed an investigation
of DM and TB in patients presenting with respiratory symptoms to a TB reference center in a
highly endemic area in Northeast Brazil. Our results revealed a previously unappreciated high
prevalence of GMD in individuals with respiratory symptoms and confirmed the previously
reported association between established DM and TB. The data also suggest that pre-DMmay
also substantially increase the odds for TB disease.
Methods
Ethics statement
This study was conducted according to the principles expressed in the Declaration of Helsinki
and was approved by the Ethics Committee of the Maternidade Climério de Oliveira, Federal
University of Bahia (CAAE—0115.0.054.000–09). Written informed consent was obtained
from all participants.
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States National Institutes of Health distributed by
CRDF Global through grant #USB1-31149-XX-13.
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Study design
The study was performed at the Instituto Brasileiro para a Investigação da Tuberculose (IBIT,
Brazilian Institute for TB investigation). This philanthropic TB primary care reference center
annually treats 10–15% TB cases of the city of Salvador, Bahia [15]. Diagnosis of TB at IBIT fol-
lows the guidelines of the Brazilian Society of Pulmonology and Tisiology [16], which is similar
to WHO recommendations [17]. For the present study, PTB diagnosis was performed as the
following: three sputum smears were examined by fluorescence microscopy, processed by the
modified Petroff’s method and cultured on Lowenstein-Jensen medium. The present study did
not perform screening for latent TB infection. At the time of this study, all identifying patient
information was either coded or redacted by IBIT. All materials given to the research team
were de-identified.
We prospectively investigated a cohort of adult patients (18 years old) with respiratory
symptoms who sought care at IBIT. The initial population consisted of all symptomatic adult
patients examined between May, 2010, and September, 2011 (n = 1,545). Symptomatic patients
were defined by the presence of cough for2 weeks in addition to at least one of the following:
fever, night sweats, malaise, weight loss, hemoptysis or dyspnea. Exclusion criteria were age
<18 years, previous diagnosis/treatment of TB, self-reported pregnancy, presence of psychiat-
ric disease that might hamper proper application of the enrollment questionnaire. All patients
were seen by nurses and physicians from IBIT at the time of initial evaluation. Of these, 192
individuals declined participation and 372 were excluded based on the study criteria. After
signing the informed consent, a standardized questionnaire about demographic characteristics,
medical history, and health-related habits was applied.
Random capillary glucose levels were measured on initial screening. Patients returned the
following day, when blood samples were obtained after an overnight fast (12 h) and tested with
an automatic clinical chemistry analyzer (Hitachi, LABOSPECT 008, Tokyo, Japan). HbA1c
was assessed by high-performance liquid chromatography using a method certified by the
National Glycohemoglobin Standardization Program. All patients also underwent a 75-g chal-
lenge oral glucose tolerance test (OGTT). The presence of DM was defined in accordance with
American Diabetes Association (ADA) guidelines as 2-h glucose11.1 mmol/L, HbA1c
6.5% or fasting plasma glucose7.0 mmol/L [18]. In patients reporting a prior history of
DM, HbA1c7.0% was used to define uncontrolled DM. Pre-DM was defined by HbA1c 5.7–
6.4%. In the present study, we define glucose metabolism disorder (GMD) as the presence of
DM or pre-DM according to ADA guidelines. An additional 89 patients were excluded from
the analyses because they either missed laboratory tests/results (n = 62) or had withdrawn con-
sent after lab tests were performed (n = 27). After all the procedures, a total of 892 individuals
were included in our analyses. The overall study design is illustrated in Fig 1.
Data analysis
Median values with interquartile ranges (IQR) were used as measures of central tendency. The
Fisher’s (two groups) or chi-square (three groups) tests were used to compare frequency data
(nominal variables). Continuous variables were compared between the study groups using the
Mann-Whitney test. Binary logistic regression analysis was used to test associations between
increasing levels of HbA1c, OGTT or fasting glucose values and the odds for PTB. Multinomial
logistic regression analyses adjusted for age, gender and body mass index (BMI) were per-
formed to assess the odds ratios (OR) of the associations between presence of DM, uncon-
trolled DM and/or smoking history and TB diagnosis. During the development of the
statistical methods, the regression models employed were validated using bootstrap (repeated
200 times). A p-value below 0.05 was considered statistically significant. The statistical analyses
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were performed using SPSS 20.0 (IBM statistics), Graphpad Prism 6.0 (GraphPad Software,
San Diego, CA) and JMP 11.0 (SAS, Cary, NC, USA).
Results
The median age of patients (n = 892) was 49 years (IQR: 38–58), the majority female (55.3%)
and median BMI was 22.6 kg/m2 (IQR: 19.8–26.2) (Table 1). Regarding lifestyle habits, 4.6% of
patients reported chronic alcoholism, 42.4% smoking history and 2.4% used illicit drugs. The
prevalence of PTB in the study population was 11.8% (n = 105). The most frequent docu-
mented comorbidities aside from TB were chronic obstructive pulmonary disease (COPD,
3.8%), HIV/AIDS (1.2%), pulmonary silicosis (2.5%) and cancer (1.1%) (Table 1). Patients
who were excluded from the study due to lack of test results and from whom we had authoriza-
tion to keep primary data (n = 62) were on average younger (median 43, IQR: 32.3–52.5 vs. 49,
38–58; p = 0.007) and more frequently reported use of illicit drugs (9.7% vs. 2.4%; p = 0.005)
than those included in the additional analyses. These two groups of patients were similar with
regard to gender (p = 0.693), smoking (p = 0.351), chronic alcoholism (p = 0.214) and comor-
bidities such as PTB (p = 0.299), HIV (p = 0.555), cancer (p = 1.0), COPD (p = 0.728) and sili-
cosis (p = 0.391) (Table 1). Patients diagnosed with PTB at the admission were more frequently
male (54.3%) and were on average younger, exhibited lower BMI values and reported more
Fig 1. Overall study design. Individuals presenting with respiratory symptoms (n = 1,545) were recruited at a TB primary care reference center in Brazil. In
two consecutive visits (1–3 days apart), all individuals were screened for diabetes / glucose metabolism disorder in the clinical interview and with laboratory
tests (glycated hemoglobin, HbA1c; oral glucose tolerance test, OGTT; fasting glucose levels). Individuals were simultaneously tested for pulmonary TB by
identification of acid-fast bacilli (AFB) in sputum smears and positive sputum culture forMycobacterium tuberculosis. Details of the study design and patient
population are described in Methods.
doi:10.1371/journal.pone.0153590.g001
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frequently chronic alcoholism compared to non-PTB individuals (Table 2). Smoking history
and frequency of comorbidities were similar between PTB and non-PTB patients (Table 2).
Within the respiratory symptoms evaluated, PTB patients exhibited higher frequency of fever,
night sweats and weight loss compared with non-PTB subpopulation (Table 2).
Table 1. Characteristics of the Study Population. For more information in study design, see Methods and Fig 1. Frequency data were compared using
the Fisher’s exact test and continuous variables (age and BMI) were compared using the Mann-Whitney test. BMI, body mass index; COPD, chronic obstruc-
tive pulmonary disease; IQR, interquartile range.
Characteristic Patients with respiratory symptoms Excluded Patients P-value
N = 892 N = 62
Female—no. (%) 493 (55.3) 36 (58.1) 0.693
Median Age—y (IQR) 49 (38–58) 43 (32.3–52.5) 0.007
Median BMI—kg/m2 (IQR) 22.6 (19.8–26.2) 22.2 (19.9–24.9) 0.225
Lifestyle habits—no. (%)
Chronic Alcoholism 41 (4.6) 5 (8.1) 0.214
Smoking 378 (42.4) 22 (35.5) 0.351
Illicit drugs use 21 (2.4) 6 (9.7) 0.005
Comorbidity—no. (%)
Pulmonary TB 105 (11.8) 4 (6.4) 0.299
HIV/AIDS 11 (1.2) 1 (1.6) 0.555
Cancer 10 (1.1) 0 (0) 1.000
COPD 34 (3.8) 3 (4.8) 0.728
Silicosis 22 (2.5) 0 (0) 0.391
doi:10.1371/journal.pone.0153590.t001
Table 2. Characteristics of PTB and non-TB patients. Patients with respiratory symptoms (n = 892) were screened for pulmonary tuberculosis (PTB) and
classified as non-PTB or PTB according to culture positivity. Frequency data were compared using the Fisher’s exact test and continuous variables (age and
BMI) were compared using the Mann-Whitney test. See Table 1 for abbreviations.
Characteristic (non-PTB / PTB) non-PTB PTB P-value
n = 787 n = 105
Female—no. (%) 787 /105 445 (56.5) 48 (45.7) 0.037
Median Age—y (IQR) 787 /105 50 (38–59) 45 (30–55) 0.0004
Median BMI—Kg/m2 (IQR) 775 /105 23.1 (20.2–26.7) 20.0 (18.3–22.7) <0.0001
Lifestyle habits—no. (%)
Chronic Alcoholism 787 /105 30 (3.8) 11 (10.5) 0.005
Smoking 787 /105 339 (43.0) 39 (37.1) 0.293
Comorbidity—no. (%)
HIV/AIDS 787 /105 11 (1.4) 0 (0) 0.628
Cancer 787 /105 10 (1.3) 0 (0) 0.616
COPD 787 /105 32 (4.1) 2 (1.9) 0.415
Silicosis 787 /105 20 (2.5) 2 (1.9) 1.000
Clinical symptoms—no. (%)
Cough 787 /105 750 (95.3) 103 (98.1) 0.304
Fever 787 /105 415 (52.7) 68 (64.8) 0.021
Night sweats 787 /105 411 (52.2) 70 (66.7) 0.006
Malaise 787 /105 581 (73.8) 75 (71.4) 0.637
Weight loss 787 /105 468 (59.5) 87 (82.8) <0.0001
Hemoptysis 787 /105 160 (20.3) 21 (20.0) 1.000
Dyspnea 787 /105 487 (61.9) 61 (58.1) 0.456
doi:10.1371/journal.pone.0153590.t002
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Study participants were screened for DM using HbA1c, OGTT and fasting glucose accord-
ing to ADA guidelines [18]. Notably, 9% (n = 80) of patients self-reported a prior diagnosis of
DM. Individuals without prior DM diagnosis (n = 812) were stratified according to HbA1c lev-
els as non-DM (HbA1c<5.7%), pre-DM (HbA1c = 5.7–6.4%) and DM (HbA1c6.5%) (Fig
2A and Table 3). Strikingly, a large majority of patients with respiratory symptoms seeking
care at the TB reference clinic exhibited some degree of GMD defined by HbA1c5.7%
(n = 563, representing 63.1% of the study population; Fig 2A). These subgroups were similar
with regard to gender distribution (female = 57.4% in non-DM vs. 54.2% in pre-DM vs. 53.7%
in DM cases; chi-square p = 0.602). Diabetic patients (newly identified and those with previous
diagnosis) were on average older than pre-DM and non-DM individuals (Table 3). In addition,
median BMI values were higher in diabetics (Table 3). Smoking history was significantly more
frequent in individuals with GMD compared with non-DM (Table 3) but the frequency of
chronic alcoholism and use of illicit drugs was similar between groups (Table 3). While the
prevalence of other comorbidities including HIV/AIDS, cancer, COPD and silicosis was not
different between the study groups, the frequency of PTB was higher in patients exhibiting
GMD (Table 3 and Fig 2B and 2C). Fully 80% of all PTB cases had HbA1c levels5.7% at the
time of diagnosis (Fig 2B), suggesting a potential association between diabetic as well as pre-
diabetic GMD with increased odds for TB.
Fig 2. Glucosemetabolism disorder is associated with TB in patients with respiratory symptoms. (A) Stratification of patients presenting with
respiratory symptoms based on HbA1c levels. (B) Frequency of abnormal HbA1c levels in patients diagnosed with pulmonary TB. (C) Frequency of TB cases
in patients without previous DM diagnosis who were classified in non-DM, pre-DM and DM based on Hb1Ac. (D) Frequency of AFB+ in sputum smears from
the entire study population. (E) Frequency of TB patients with different AFB smear grades in sputum classified according to altered HbA1c levels. (F)
Prevalence of TB-related symptoms relative to the study population was compared between non-DM, pre-DM and DM TB patients without previous DM
diagnosis. (G) Individuals were further categorized in polysymptomatic (> 3 symptoms) or non-polysymptomatic ( 3 symptoms). In (C), (D), (F) and (G), data
were compared using the chi-square test.
doi:10.1371/journal.pone.0153590.g002
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An important parameter related to TB transmission is presence of acid-fast bacilli (AFB) in
sputum smears [19]. Positive sputum smears have also been linked to greater TB disease sever-
ity and inflammatory profile [20,21]. In the present study, prevalence of AFB+ sputum smear
in the study population was significantly higher in newly diagnosed DM cases compared to
pre-DM and non-DM individuals (p = 0.0003; Fig 2D). In addition, frequency of individuals
presenting altered HbA1c levels was shown to be higher in PTB patients regardless of the AFB
status (Fig 2E). We next tested whether non-DM, pre-DM or DM individuals differed in terms
of disease presentation based on the prevalence of TB-related symptoms (cough, fever, night
sweats, malaise, weight loss, hemoptysis and dyspnea). The frequency of TB-related symptoms
increased progressively, following the degree of GMD (Fig 2F). Indeed, newly diagnosed dia-
betic patients displayed the highest frequency of polysymptomatic individuals compared to the
groups of those with pre-DM and non-DM (p<0.0001; Fig 2G). These results reinforce the
idea that coincident TB-DM is associated with more severe TB presentation.
Within the total study population, 9% (n = 80) of individuals self-reported prior DM diag-
nosis. The median HbA1c level in this subpopulation was 8.45% (Fig 3A). Of these patients, six
(7.5%) exhibited HbA1c values at normoglycemic level (HbA1c<5.7%) and 15 (18.75%) dis-
played levels compatible with pre-DM (HbA1c = 5.7–6.4%). Of note, 68.7% (n = 55) of those
Table 3. Characteristics of patients classified according to Hb1Ac levels. Patients with respiratory symptoms (n = 892) were screened for diabetes
(DM) and classified as non-DM, pre-DM or DM following the American Diabetes Association criteria (non-DM: HbA1c < 5.7%, pre-DM: HbA1c 5.7–6.4%, DM:
referred DM or HbA1c 6.5%). Frequency data were compared using the chi-square test and continuous variables (age and BMI) were compared using the
Kruskal-Wallis test. See Table 1 for abbreviations.
Characteristic (non-DM /pre-DM /all DM) non-DM pre-DM all DM cases P-value
n = 329 n = 358 n = 205
Female—no. (%) 329 /358 /205 189 (57.4) 194 (54.2) 110 (53.7) 0.602
Median Age—y (IQR) 329 /358 /205 42 (32–53) 50 (39–58) 56 (48–65) <0.0001
Median BMI—Kg/m2 (IQR) 327 /352 /204 22.2 (19.6–25.0) 22.8 (20.2–27.4) 22.9 (19.7–26.8) 0.026
Lifestyle habits—no. (%)
Chronic Alcoholism 328 /358 /205 14 (4.2) 16 (4.5) 11 (5.4) 0.828
Smoking 328 /357 /205 106 (32.2) 176 (49.3) 96 (46.8) <0.0001
Illicit drugs use 329 /358 /205 9 (2.7) 10 (2.7) 2 (1.0) 0.332
Comorbidity—no. (%)
Pulmonary TB 329 /358 /205 21 (6.4) 40 (11.2) 44 (21.5) <0.0001
HIV/AIDS 328 /358 /205 5 (1.5) 3 (0.8) 3 (1.5) 0.680
Cancer 328 /358 /205 3 (0.9) 4 (1.1) 3 (1.5) 0.840
COPD 328 /358 /205 14 (4.3) 12 (3.3) 8 (3.9) 0.823
Silicosis 328 /358 /205 7 (2.1) 11 (3.1) 4 (1.9) 0.628
Clinical symptoms—no. (%)
Cough 329 /358/ 205 21 (6.4) 39 (10.9) 43 (21.0) 0.004
Fever 329 /358/ 205 17 (5.2) 25 (7.0) 26 (12.7) <0.0001
Night sweats 329 /358/ 205 11 (3.3) 27 (7.5) 32 (15.6) <0.0001
Malaise 329 /358/ 205 14 (4.2) 26 (7.3) 35 (17.0) <0.0001
Weight loss 329 /358/ 205 19 (5.8) 30 (8.4) 38 (18.5) 0.004
Hemoptysis 329 /358/ 205 5 (1.5) 5 (1.4) 11 (5.4) 0.0009
Dyspnea 328 /358/ 205 13 (3.9) 24 (6.7) 24 (11.7) 0.007
AFB status in PTB patients—no. (%) 21 /40 /44 0.347
Negative 11 (52.4) 21 (52.5) 17 (38.6)
Positive 10 (47.6) 19 (47.5) 27 (61.4)
doi:10.1371/journal.pone.0153590.t003
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patients had HbA1c7.0%, indicating poor glycemic control (Fig 3A). Individuals with
uncontrolled DM were similar to those with HbA1c<7.0% with regard to age, BMI, gender
distribution, lifestyle habits and most of the comorbidities screened (Table 4). Interestingly, the
frequency of TB diagnosis was almost 4 times higher in the group of patients with poor glyce-
mic control compared with individuals with HbA1c<7.0% (30.9% vs. 8.0%, respectively,
p = 0.026; Table 4 and Fig 3B). Notably, among active TB cases with previous DM diagnosis,
individuals with HbA1c7.0% accounted for the majority of AFB+ samples (Fig 3B). Linear
regression analysis adjusted for age, gender and BMI confirmed the strong association between
heightened values of HbA1c, fasting glucose or OGTT and prevalence of TB in this study popu-
lation (Fig 3C).
Cigarette smoking is an independent risk factor for pulmonary TB [3]. A prospective
14-year cohort study of over 1.2 million South Koreans showed that smoking was associated
with increased mortality from TB in men and women, with similar risks for current and for-
mer smokers [22]. In our study, 42.4% of the subjects reported smoking history (Table 5 and
Fig 4A). Female gender was more prevalent in the group of non-smokers (Table 5). Former
smokers were older (Table 5). BMI was higher in non-smokers, while current smokers had
more deleterious life style habits than the other groups (Table 5). Frequency of HIV/AIDS,
Fig 3. Worse glycemic control is associated with pulmonary TB. (A) Left panel shows Hb1Ac levels in individuals who self reported previous diagnosis of
diabetes. Full line represents median value (Hb1Ac = 8.45%). Dotted lines represent thresholds of Hb1Ac used to define normoglycemic levels (5.7%) and
uncontrolled DM (7.0%) according to the ADA criteria [18]. Right panel shows frequency of individuals with respiratory symptoms who had referred previous
diagnosis of diabetes and presented with poor glycemic control (HbA1c 7.0%). (B) Frequency of TB diagnosis (left panel) in patients referring previous DM
diagnosis, with or without HbA1c 7.0%. Right panel shows frequency of TB cases with AFB+ sputum smears. The Fisher's exact test was used to assess
statistical significance. (C) Linear regression analysis adjusted for age, gender and BMI was used to determine the association between increases of 1 unit in
plasma values of HbA1c, fasting glucose or OGTT glycaemia (after log10 transformation) and pulmonary TB in the entire study population (n = 892). The
odds associated with the covariates used in the model adjustment are displayed in S1 Table.
doi:10.1371/journal.pone.0153590.g003
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cancer, COPD and silicosis was not different between the groups stratified according to
smoking history (Table 5). Contrasting with data from the Korean population20, the preva-
lence of pulmonary TB among our Brazilian cohort was not increased in subjects with smok-
ing history compared to non-smokers (12.4% in current smokers vs. 9.2% in former smokers
vs. 12.8% in non-smokers, p = 0.359; Table 5). Even when all patients with any smoking his-
tory were pooled in a single group, we could not detect a significant difference in TB preva-
lence compared with non-smokers (p = 0.293; Fig 4B). Furthermore, within the group of PTB
patients (n = 105), the frequency of TB-related symptoms was not different between non-
smoking individuals and those with smoking history (Fig 4C), suggesting that smoking did
not impact the disease presentation profile in our study population. Nevertheless, we detected
a significantly increased incidence of AFB+ sputum smears in smokers compared with non-
smokers (p = 0.044; Fig 4D). The combination of smoking and DM has been described to
cause a synergistic effect on the risk of death within 12 months of TB diagnosis [23,24]. In the
present study, the prevalence of GMD was substantially higher in the group of individuals
referring smoking history than in non-smokers (p<0.0001; Fig 4E). Finally, we performed
multinomial logistic regression analysis adjusted for age, gender and BMI to assess direct
associations between smoking history, DM or the combination of these two risk factors and
incidence of TB diagnosis. We found that smoking history alone was not significantly associ-
ated with increased odds for PTB (adjusted OR: 1.2, 95% CI: 0.80–2.08, p = 0.291; Fig 4F). As
expected by our preliminary analyses, DM was significantly associated with TB (Fig 4F). The
strength of association was even higher when only uncontrolled DM was considered (HbA1c
7.0%) (Fig 4F). When smoking history and DM were considered together, we observed a
significant association with PTB (adjusted OR: 4.4, 95% CI: 2.7–7.4, p<0.0001; Fig 4F).
Importantly, individuals with combined smoking history and uncontrolled DM (HbA1c
7.0%) exhibited 6 times greater odds for PTB diagnosis than those without these risk factors
(adjusted OR: 6.3, 95% CI: 3.5–11.3, p<0.0001; Fig 4F).
Table 4. Characteristics of population with previous diagnosis of diabetes according to the glycemic control status. Patients with respiratory symp-
toms who referred previous DM diagnosis (n = 80) were classified according to the glycemic control status based on HbA1c levels. Frequency data were com-
pared using the Fisher’s exact test and continuous variables (age and BMI) were compared using the Mann-Whitney test. No patients in these groups
referred illicit drugs use. See Table 1 for abbreviations.
Characteristic (HbA1c <70% / HbA1c  70%) HbA1c <70% HbA1c  70% P-value
n = 25 n = 55
Female—no. (%) 25 /55 11 (44.0) 34 (61.8) 0.152
Median Age—y (IQR) 25 /55 63 (54.5–77.0) 58 (49.0–66.0) 0.063
Median BMI—Kg/m2 (IQR) 24 /55 24.9(16.6–26.0) 22.5 (19.5–26.1) 0.359
Lifestyle habits—no. (%)
Chronic Alcoholism 25 /55 2 (8.0) 2 (3.6) 0.585
Smoking 25 /55 13 (52.0) 19 (34.5) 0.462
Comorbidity—no. (%)
Pulmonary TB 23 /52 2 (8.7) 17 (32.7) 0.042
HIV/AIDS 25 /55 1 (4.0) 1 (1.8) 0.530
Cancer 25 /55 2 (8.0) 0 (0) 0.094
COPD 25 /55 1 (4.0) 1 (1.8) 0.530
Silicosis 25 /55 0 (0) 3 (5.4) 0.548
AFB status in PTB patients—no. (%) 02 /17 0.485
negative 0 (0) 8 (47)
positive 2 (100) 9 (53)
doi:10.1371/journal.pone.0153590.t004
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Discussion
A relationship between DM and TB has been appreciated for several years [8] but has only
lately been a focus of research. Worldwide DM has increased by ~20% in the past three
decades, high with the greatest increase in low and middle-income countries [25]. In these
countries, where TB is among the primary causes of death, this dual burden leads to substantial
impact on public health [5]. Reinforcing this idea, we have recently shown that TBDM patients
exhibit worse clinical TB presentation and adverse outcomes compared to non-DM TB indi-
viduals from Brazil [14]. The present study examined the interaction between plasma glucose
levels and PTB in a TB-endemic area of Brazil. We found a high prevalence of GMD in patients
presenting with respiratory symptoms at a TB primary care center. Whether TB promotes
GMD in susceptible people or if GMD directly affects TB susceptibility is incompletely under-
stood but both effects are likely and each has important implications for public health. A pre-
ponderance of evidence suggests that DM impairs human immunity to TB, increasing the risk
for progression of latent TB infection and the severity of TB disease [8,26]. Results from our
study and others, suggest that a broader spectrum of GMD, including pre-DM, may have a
similar effect [27,28]. If this were true, then the TB burden attributable to metabolic syndromes
Table 5. Characteristics of population according to smoking status. Patients with respiratory symptoms (n = 892) were classified as current smokers,
former smokers and non-smokers. Frequency data were compared using Chi-square test and continuous variables (age and BMI) were compared using the
Kruskal-Wallis test. See Table 1 for abbreviations.
Characteristic (current smoker /former smoker /non-
smoker)
Current
smoker
Former smoker Non-smokers P-value
n = 140 n = 238 n = 514
Female—no. (%) 140 /238 /514 59 (42.1) 109 (45.8) 325 (63.2) <0.0001
Median Age—y (IQR) 140 /238 /514 51.5 (41–58) 54.5 (46–63) 45 (34.0–55.0) <0.0001
Median BMI—Kg/m2 (IQR) 138 /234 /509 20.66 (18.9–
23.6)
22.82 (20.4–
27.4)
23.2 (20.1–
26.6)
<0.0001
Lifestyle habits—no. (%)
Chronic Alcoholism 140 /238 /513 20 (14.3) 7 (2.9) 14 (2.7) <0.0001
Illicit drugs use 140 /238 /513 15 (10.7) 6 (2.5) 0 (0) <0.0001
Comorbidity—no. (%)
Pulmonary TB 140 /238 /514 17 (12.1) 22 (9.2) 66 (12.8) 0.359
HIV/AIDS 140 /238 /514 4 (2.9) 3 (1.3) 4 (0.8) 0.141
Cancer 140 /238 /514 0 (0) 7 (2.9) 3 (0.6) 0.006
COPD 140 /238 /514 6 (4.3) 13 (5.5) 15 (2.9) 0.226
Silicosis 140 /238 /514 4 (2.9) 11 (4.6) 7 (1.4) 0.026
Clinical symptoms in TB patients-
no. (%)
cough 17 /22 /66 17 (100) 21 (95.4) 65 (98.5) 0.547
fever 17 /22 /66 11 (64.7) 13 (59.1) 44 (66.7) 0.812
night sweats 17 /22 /66 12 (70.6) 14 (63.6) 44 (66.7) 0.901
malaise 17 /22 /66 10 (58.8) 15 (68.2) 50 (75.7) 0.360
weight loss 17 /22 /66 13 (76.5) 18 (81.8) 56 (84.8) 0.708
hemoptysis 17 /22 /66 4 (23.5) 5 (22.7) 12 (18.2) 0.830
dyspnea 17 /22 /66 6 (35.3) 13 (59.1) 42 (63.6) 0.106
AFB status in PTB patients—no. (%) 17 /22 /66 0.060
negative 4 (24) 9 (41) 36 (54)
positive 13 (76) 13 (59) 30 (46)
doi:10.1371/journal.pone.0153590.t005
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would be far greater than is currently estimated for DM alone. Protective immunity against TB
might also be affected by glucose-independent pathways. This concept is supported by evi-
dence that pre-diabetic GMD in non-diabetic individuals is associated with increased risk vas-
cular complications [29,30]. An alternative, but not mutually exclusive hypothesis is that the
inflammatory stress of active TB leads to insulin resistance and/or reduced beta cell function,
thereby promoting GMD (or deteriorating DM disease) with implications for bidirectional
screening and for DM prevention [31,32].
The majority (63.1%) in our cohort of patients with respiratory symptoms exhibited some
degree of GMD. Patients with GMD in our cohort not only had higher prevalence of TB but
were also more likely to have TB-related symptoms. These results argue that GMD affects TB
disease severity. This is consistent with other studies reporting that comorbid DM increases
the odds of positive sputum smear, cavitation, delayed sputum conversion, treatment failure
and recurrent TB [8,12,28], all of which increase the risk of transmission to the general popula-
tion. In addition, we found that up to 69% of the individuals self-reporting previous DM diag-
nosis had HbA1c 7.0%, indicating poor glycemic control. Notably, TB prevalence was higher
in individuals with HbA1c 7.0% compared with those with controlled DM, reinforcing the
association between poor glycemic control and TB [30]. Regression analyses adjusted for age,
Fig 4. Associations between cigarette smoking, glycemic control and pulmonary tuberculosis. (A) Frequency of smokers in the entire study
population. (B) Frequency of TB diagnosis in smoking and non-smoking individuals with respiratory symptoms. (C) Prevalence of TB-related symptoms was
compared between smoking and non-smoking PTB patients. (D) Frequency of AFB+ in sputum smears from smoking and non-smoking TB patients. In (B),
(C) and (D), data were compared using the Fisher’s exact test. (E) Frequency of non-DM, pre-DM, DM (stratified according to HbA1c values) and those who
referred previous diagnosis of DM in the groups of smoking or non-smoking individuals. Data were compared using the chi-square test. (F) Multinomial
regression analysis adjusted for age, gender and BMI, was perform to test the association of the indicated conditions and pulmonary TB. The odds
associated with the covariates used in the model adjustment are displayed in S1 Table.
doi:10.1371/journal.pone.0153590.g004
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gender and BMI demonstrated that increased plasma values of HbA1c, fasting glucose or
OGTT glycaemia were all independently associated with TB in symptomatic respiratory
patients, even those falling below the ADA cutoff for DM.
In the present study we found an increased prevalence of GMD in patients with a history of
smoking. Prospective studies from South Korea concluded that smoking increases risk of inci-
dence, mortality and recurrence of TB [22,24]. In our Brazilian cohort, where 42.4% of indi-
viduals were past or current smokers, there was no statistically significant association between
smoking and incident TB. In addition, we found no difference in frequency of TB-related
symptoms in smokers vs. nonsmokers. Nevertheless, in patients diagnosed with TB, smoking
history was associated with higher frequency of positive sputum AFB smear. The lack of asso-
ciation between smoking and incident TB observed here might be attributable to an enrich-
ment of female patients in our cohort, since a Korean study found that the association of TB
with smoking was limited to male gender [22]. Another Korean cohort study reported that the
combination of smoking and DM have a synergistic effect on all-cause mortality and TB-
related mortality within 12 months of ATT initiation, after adjusting for other confounders
[24]. Multinomial logistic regression analyses of data from our Brazilian cohort confirmed this
synergistic effect of smoking and uncontrolled DM (HbA1c7.0%) on increased association
with TB. The mechanisms driving this association remain unknown and merit further
investigation.
Our data shows no difference in COPD prevalence with respect to smoking history. The
association between COPD and smoking is dependent on the number of cigarettes and fre-
quency of smoking. We did not have information on either of these parameters. It is possible
that the tobacco burden (pack-years) was low in this population. In addition, the overall fre-
quency of COPD in our study population was low (34 out of 892 individuals). It is possible that
the overall low frequency of COPD could have reduced the power to detect differences induced
by smoking. Lastly, documentation of COPD was based on self-report, and we did not employ
spirometric assays to diagnose this condition. Importantly, there is published evidence for
COPD in non-smokers, which is reported at different rates in different countries and popula-
tions with the lowest rate in developed nations with good air quality and industrial hygiene
enforcement and highest rates in countries with the worst air pollution and biomass combus-
tion [33].
Our study has several limitations. Our study lacked systematic evaluation of radiographic
data on TB disease. We thus were unable to analyze prevalence of cavitary lesions and extent of
lung disease (unilateral/bilateral) between the study groups. A previous study from our group
performed in the same TB reference center revealed that occurrence of cavitation in TB
patients was not affected by DM [14]. We did not have access to information regarding DM
severity (time since diagnosis and the presence of DM-related complications). Nor was there
data on other metabolic comorbidities such as dyslipidemia or vitamin D insufficiency that
have increased prevalence in DM patients and may contribute to TB susceptibility. Our conclu-
sions are also limited by lack of information on treatment response, TB outcomes and glycemic
status at the completion of ATT. Additional prospective studies are needed to define the indi-
vidual and cumulative impact of metabolic disorders and lifestyle habits on TB susceptibility
and outcomes and the impact of TB on glycemic status.
In summary, our data indicate that sustained diabetic hyperglycemia, as well as pre-diabetic
GMD, increases the risk for PTB in Brazilian patients with respiratory symptoms. We further
found an adverse combinatorial effect of GMD and smoking on TB risk in this population. In
such epidemiological settings, bidirectional screening and integrated management may help to
improve early diagnosis and clinical outcomes for both TB and DM.
Glucose Metabolism Disorder and Tuberculosis in Brazil
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